A cross-sectional observational study to identify the current status of shared decision making and factors influencing decision making of drug treatment among gynecological cancer patients and health care providers

JRCT ID: jRCT1040220088

Registered date:04/11/2022

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Gynecological cancer (uterine cancer, ovarian cancer/fallopian tube cancer)
• Date of first enrollment: 04/11/2022
• Target sample size: 590
• Study type: Observational

Outcome(s)

Primary Outcome

- Current status of SDM (Desirability and reality of reflecting patients' own values in their decision making)
- Differences in what patients and health care professionals consider important when choosing drug treatment.

Secondary Outcome

- Preference for multidisciplinary intervention in decision-making by patients and health care professionals, and the type of work desired.
- Background factors associated with decision-making type
- Identification of the most distressing side effects experienced by the patient

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Female

Include criteria

<Patients>
- Agreed web questionnaire survey.
- 18 year and older.
- Live in Japan.
- Received chemotherapy for uterine cancer, ovarian cancer, or fallopian tube cancer.
<Health care providers>
- Agreed web questionnaire survey.
- Doctors, nurses, or pharmacists who are engaged in drug treatment for gynecological cancer.

Exclude criteria

<Patients>
- Have families engaged in pharmatheutical/survey/marketing company or health care.
- Have double cancer.
<Health care providers>
- Doctors with less than 5 years of experience as a doctor (including training period).
- Nurses and pharmacists with less than 1 year of experience.

Related Information

• Primary Sponsor: Kitano Hiromi